B. Craig Granowitz's most recent trade in Lexicon Pharmaceuticals Inc was a trade of 74,227 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 74,227 | 148,453 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 74,227 | 185,560 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 28 Feb 2025 | 65,308 | 120,252 (0%) | 0% | 0.7 | 43,756 | Common Stock |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 35,790 | 111,333 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 35,790 | 35,790 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 27,917 | 75,543 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 27,917 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 910,170 | 910,170 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 606,780 | 606,780 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Granowitz Craig B. | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 35,790 | 78,891 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | Granowitz B. Craig | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 35,790 | 71,580 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | B. Granowitz Craig | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share. | 28 Feb 2024 | 31,265 | 47,626 (0%) | 0% | 2.6 | 81,914 | Common Stock |
| Lexicon Pharmaceuticals Inc | Craig Granowitz B. | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 27,916 | 43,101 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | B. Craig Granowitz | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 27,916 | 27,917 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Granowitz B. Craig | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 222,680 | 222,680 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 222,680 | 222,680 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 27,917 | 27,917 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 27,917 | 55,833 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. | 28 Feb 2023 | 12,732 | 15,185 (0%) | 0% | 2.2 | 27,628 | Common Stock |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 322,110 | 322,110 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 107,370 | 107,370 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 251,250 | 251,250 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 83,750 | 83,750 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) |